We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Nthn.Investors | NRI | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 186.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 186.00 | 186.00 |
| Top Posts |
|---|
Posted at 12/7/2017 22:06 by westcountryboy New NAV figure of 222.8p per share post divi has led to further share price falls. As we are still 60p over the NAV it will be interesting if this falls further, or whether investors remain cooler and still quietly hope that in addition to the £5.57m net assets remaining after the divi payment they may get at least £0.96m in deferred sale proceeds and up to £1.74m for the performance fee provision, making £8m = 320p per share before any increase in value of the remaining companies is factored in. |
Posted at 05/7/2017 20:16 by westcountryboy I can see why the price has fallen: now the divi has been paid the market is confronted with the statement in the annual report that the final return from here is anticipated to be between 240p-400p, or £6m-£10m - so we are pretty much in the middle of that range. The current buy price of 315p equates to £7.9m NAV against a NAV of only £5.8m for the four remaining companies. The 400p/£10m upper range estimate depends on three things happening in my opinion:1) an uplift in at least some of the remaining four companies before sale - the most promising being Axial - but none of them are laying golden eggs in the way that some of the previous holdings were 2) further payments for sold companies eg Optilan (up to £1.2m might be possible according to the report) 3) a lot of the money reserved on the balance sheet for performance fee not being needed. £1.75m is currently reserved in my estimation on top of (only) £771k used this year - difficult to see why much should be needed next year, but as I don't know the terms of the scheme I may be wrong! Other views welcome! WCB |
Posted at 05/7/2017 11:17 by westcountryboy Yes, just bought some more this morning in fact, for 311.25. Perhaps a mistake! 30p of the fall was dividend last Thursday - I hope the rest was just bored people ex-divi fed up with the long wait to come... |
Posted at 20/1/2017 10:55 by westcountryboy XD today but even so very strange response. It was possible to sell yesterday at 933.5, and the divi is 250p. Let's hope things sort themselves out in the near future! |
Posted at 20/5/2016 14:27 by westcountryboy Hi SBPEach to his own! On the more optimistic side: - of net assets of £17m, £10m is cash - there is a dividend of 24p in the offing - 'It is still our objective that the return of cash to shareholders should be substantially completed by December 2017; our latest review indicates that the further amount to be returned could be in the range from GBP18 million to GBP23 million, making an ultimate total of between GBP95 million and GBP100 million. This is equivalent to between 160% and 170% of the net assets at the start of the realisation process, and implies future cash distributions of between 720 pence and 920 pence for each share now in issue.' - there are only six remaining companies of note, all seemingly rather healthy, and only two of which (Weldex and CGI) are worth less than they cost : Axial Systems Holdings 3,519 Optilan Group 2,747 Cawood Scientific 1,984 Weldex (International) Offshore Holdings 1,921 CGI Group Holdings 819 Lanner Group 730 - as discussed before on this thread, the £5m bonus set off against assets is very unlikely all to be needed |
Posted at 07/3/2016 18:55 by garbetklb Rather odd that there's no mention as to where NRI holding has been sold - nothing on Control Risks web site or Twitter, so looks like it's a private sale of the NRI holding only.Will be interested to see which holdings are left - and valuations. |
Posted at 25/2/2016 16:15 by skyship Posted on NRI back on 1st Feb. Thanks to WCB for flagging up the cheap offer as I bought then @ 516p and sold today @ 630p...perhaps too early, but couldn't resist a turn of that order in these difficult times.Thnx again WCB. |
Posted at 29/5/2015 15:34 by nk104 Not sure if anyone else is still in but I've got a residual holding.Annual results out: Dividend Since 2013 the annual dividend has been paid in the form of a single final dividend, with no interim dividend being declared. The proposed dividend for the year ended 31 March 2015 is 17.0 pence per share, a 70% increase from last year's 10.0 pence. This is the nineteenth consecutive year in which the dividend per share has been increased. Subject to approval by shareholders at the annual general meeting on 7 July 2015, the final dividend will be paid on 24 July 2015 to shareholders on the register on 3 July 2015. |
Posted at 05/4/2015 18:25 by skyship Posted this elsewhere today. Thought I might as well copy it here:==================== WHERE TO NEXT… I see it was back on 1st Sep'10 that I created the thread for liquidating Private Equity trust HPEQ. After that paid off in no uncertain terms, I cast around for a worthy successor and happily alighted upon the liquidating NRI, starting the thread here on 26th Jul'12. NRI has actually done even better than HPEQ, with the price more than doubling. We've had three Tenders along the way; and the third at 500p which closed last week is likely to provide my exit; though there could remain a small rump which I will hold and wait for an IPO of the largest portfolio holding - Control Risks. Private Equity remains my most profitable investment sector; and all along I should have had a higher weighting in NRI. Now I am looking for the next PE contender to carry the HPEQ/NRI torch. Happily there is a third, small, liquidating Private Equity trust – MITHRAS Inv. Tst. – “MTH” MTH is an admirable successor, though the returns will now not be so great as we have already had three tenders and a rising share price over the past two years. No matter, MTH looks highly likely to continue paying out favourable dollops, indeed the Board actually states that MTH is still quite early on in its liquidation. I look forward to another Tender later this year; and the shares can be bought at 146p at a good discount to the likely Tender price – see this link to my Post No.140 on ADVFN’s MTH thread: MTH is a tight Market, so if not already in there and tempted to buy a few, perhaps best set your limit to, say, 147p and wait rather than bidding up. ==================== Two other PE trusts well worth considering: # JP Morgan Private Equity – JPEL. This is now my largest holding thanks to continuing strength and a couple of top-ups lower down. In spite of its rise JPEL @ 93c offers a very attractive 23.8% NAV discount – much higher than the average of 18% for its peers. NB: Yes, JPEL is LSE listed but quoted in US$; so the currency has also added to past performance; and may continue to do so… # BP Marsh – BPM. This is another small trust; and a bit of a specialist being solely in the Insurance broker sector – a Market sector doing very well and going through an active period of consolidation. The major attraction here is the excessive NAV discount of 30%. That should close to something akin to the 18% sector average. That alone would raise the price 16% from the current offer price of 144p to 168p. |
Posted at 31/3/2015 15:51 by skyship Well, having accepted the Tender for all of my whole holding, I calculate a minimum of 67.53% will have been accepted; though more likely nearer 80% due to others in the Nominee account not assenting.NRI has done all I could have hoped of it when I chose it as my principal PE investment after the great run with HPEQ. Rather than buy any back I'll be adding to my holdings in two other PE plays - BPM & MTH. I'll run my very small rump holding in NRI; and expect to see an IPO in Control Risks at some stage. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
